Page last updated: 2024-10-22

alendronate and Carcinoma 256, Walker

alendronate has been researched along with Carcinoma 256, Walker in 3 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Carcinoma 256, Walker: A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
" The findings suggest that there is no pharmacodynamic advantage for continuous infusion of alendronate."1.31Pharmacokinetic and pharmacodynamic evaluation of intermittent versus continuous alendronate administration in rats. ( Golomb, G; Hoffman, A; Stepensky, D, 2002)
"To validate our hypothesis that a bisphosphonate (BP) having a nitrogen-containing heterocyclic ring on the side chain, and with no hydroxyl on the geminal carbon would possess increased activity, and better oral bioavailability due to enhanced solubility of its calcium complexes/salts and weaker Ca chelating properties."1.30Synthesis and preclinical pharmacology of 2-(2-aminopyrimidinio) ethylidene-1,1-bisphosphonic acid betaine (ISA-13-1)-a novel bisphosphonate. ( Alferiev, IS; Breuer, E; Cohen, H; Ezra, A; Golomb, G; Hägele, G; Hoffman, A; Mönkkönen, J; Ornoy, A; Patlas, N; Pinto, T; Sagi, H; Seibel, MJ; Solomon, V; Stepensky, D, 1999)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, H1
Alferiev, IS1
Mönkkönen, J1
Seibel, MJ1
Pinto, T1
Ezra, A1
Solomon, V1
Stepensky, D2
Sagi, H1
Ornoy, A1
Patlas, N1
Hägele, G1
Hoffman, A2
Breuer, E1
Golomb, G2
Kozak, S1
Rizzoli, R1
Trechsel, U1
Fleisch, H1

Other Studies

3 other studies available for alendronate and Carcinoma 256, Walker

ArticleYear
Synthesis and preclinical pharmacology of 2-(2-aminopyrimidinio) ethylidene-1,1-bisphosphonic acid betaine (ISA-13-1)-a novel bisphosphonate.
    Pharmaceutical research, 1999, Volume: 16, Issue:9

    Topics: Administration, Oral; Alendronate; Animals; Antineoplastic Agents; Betaine; Bone Diseases; Bone Neop

1999
Pharmacokinetic and pharmacodynamic evaluation of intermittent versus continuous alendronate administration in rats.
    Journal of pharmaceutical sciences, 2002, Volume: 91, Issue:2

    Topics: Alendronate; Animals; Bone Neoplasms; Bone Resorption; Calcium; Carcinoma 256, Walker; Drug Administ

2002
Effect of a single injection of two new bisphosphonates on the hypercalcemia and hypercalciuria induced by Walker carcinosarcoma 256/B in thyroparathyroidectomized rats.
    Cancer research, 1987, Dec-01, Volume: 47, Issue:23

    Topics: Alendronate; Animals; Bone Resorption; Calcium; Carcinoma 256, Walker; Diphosphonates; Hypercalcemia

1987